Showing results (1181-1190 of 2,107) with videos related to

Sort By:
Pageof 211
CNS Drugs|May 20, 2003
Vaccines for Alzheimer's disease: how close are we?Christopher Janus
CNS Drugs|May 31, 2003
Management of neurocysticercosisTerrence Riley, A C White
CNS Drugs|December 10, 2003
Clinical potential of omega-3 fatty acids in the treatment of schizophreniaRobin Emsley, Piet Oosthuizen, Susan J van Rensburg
CNS Drugs|November 5, 2003
Can the time window for administration of thrombolytics in stroke be increased?Geoffrey A Donnan, David W Howells, Romesh Markus, et al.
CNS Drugs|November 5, 2003
Pharmacological management of neuropathic painGary McCleane
CNS Drugs|November 5, 2003
The cost-benefit of cholinesterase inhibitors in mild to moderate dementia: a willingness-to-pay approachGrace Wu, Krista L Lanctôt, Nathan Herrmann, et al.
CNS Drugs|January 21, 2004
Cognitive effects of long-term benzodiazepine use: a meta-analysisMelinda J Barker, Kenneth M Greenwood, Martin Jackson, et al.
CNS Drugs|October 16, 2019
Effects of Fampridine in People with Multiple Sclerosis: A Systematic Review and Meta-analysisMaxime Valet, Mélanie Quoilin, Thierry Lejeune, et al.
CNS Drugs|October 17, 2019
Modulation of the Endocannabinoid and Oxytocinergic Systems as a Potential Treatment Approach for Social Anxiety DisorderRafael Guimarães Dos Santos, Flávia de Lima Osório, Rocio Martin-Santos, et al.
Pageof 211